Annual SGA
$119.03 M
-$55.41 M-31.76%
December 31, 2024
Summary
- As of March 12, 2025, VIR annual SGA is $119.03 million, with the most recent change of -$55.41 million (-31.76%) on December 31, 2024.
- During the last 3 years, VIR annual SGA has fallen by -$41.76 million (-25.97%).
- VIR annual SGA is now -31.76% below its all-time high of $174.44 million, reached on December 31, 2023.
Performance
VIR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$26.70 M
+$957.00 K+3.72%
December 31, 2024
Summary
- As of March 12, 2025, VIR quarterly SGA is $26.70 million, with the most recent change of +$957.00 thousand (+3.72%) on December 31, 2024.
- Over the past year, VIR quarterly SGA has dropped by -$3.56 million (-11.78%).
- VIR quarterly SGA is now -52.13% below its all-time high of $55.78 million, reached on December 31, 2021.
Performance
VIR Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.16 B
-$521.96 M-31.87%
December 31, 2024
Summary
- As of March 12, 2025, VIR TTM SGA is -$2.16 billion, with the most recent change of -$521.96 million (-31.87%) on December 31, 2024.
- Over the past year, VIR TTM SGA has dropped by -$2.31 billion (-1552.40%).
- VIR TTM SGA is now -240.27% below its all-time high of $1.54 billion.
Performance
VIR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
VIR Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.8% | -11.8% | -1552.4% |
| 3 y3 years | -26.0% | -42.9% | -1368.2% |
| 5 y5 years | +216.6% | -42.9% | -1368.2% |
VIR Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -31.8% | at low | -52.1% | +3.7% | -240.3% | +10.5% |
| 5 y | 5-year | -31.8% | +216.6% | -52.1% | +126.1% | -240.3% | +26.6% |
| alltime | all time | -31.8% | +448.7% | -52.1% | +261.1% | -240.3% | +26.6% |
Vir Biotechnology Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $119.03 M(-31.8%) | $26.70 M(+3.7%) | $118.98 M(-10.9%) |
| Sep 2024 | - | $25.74 M(-14.9%) | $133.50 M(-10.2%) |
| Jun 2024 | - | $30.27 M(-16.6%) | $148.69 M(-9.3%) |
| Mar 2024 | - | $36.27 M(-12.0%) | $163.94 M(-6.0%) |
| Dec 2023 | $174.44 M(+7.8%) | $41.22 M(+0.7%) | $174.44 M(+1.4%) |
| Sep 2023 | - | $40.93 M(-10.1%) | $171.97 M(-1.3%) |
| Jun 2023 | - | $45.51 M(-2.7%) | $174.21 M(+2.3%) |
| Mar 2023 | - | $46.78 M(+20.7%) | $170.28 M(+5.3%) |
| Dec 2022 | $161.76 M(+0.6%) | $38.74 M(-10.3%) | $161.76 M(-9.5%) |
| Sep 2022 | - | $43.17 M(+3.8%) | $178.80 M(-3.9%) |
| Jun 2022 | - | $41.59 M(+8.7%) | $186.12 M(+7.4%) |
| Mar 2022 | - | $38.26 M(-31.4%) | $173.31 M(+7.8%) |
| Dec 2021 | $160.79 M | $55.78 M(+10.5%) | $160.79 M(+25.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $50.50 M(+75.4%) | $128.06 M(+32.8%) |
| Jun 2021 | - | $28.78 M(+11.8%) | $96.42 M(+14.8%) |
| Mar 2021 | - | $25.74 M(+11.7%) | $84.03 M(+18.5%) |
| Dec 2020 | $70.94 M(+88.7%) | $23.04 M(+22.2%) | $70.94 M(+18.8%) |
| Sep 2020 | - | $18.86 M(+15.1%) | $59.70 M(+19.3%) |
| Jun 2020 | - | $16.39 M(+29.5%) | $50.06 M(+20.1%) |
| Mar 2020 | - | $12.65 M(+7.1%) | $41.69 M(+10.9%) |
| Dec 2019 | $37.60 M(+29.1%) | $11.81 M(+28.1%) | $37.60 M(+11.4%) |
| Sep 2019 | - | $9.22 M(+15.1%) | $33.74 M(+5.7%) |
| Jun 2019 | - | $8.01 M(-6.4%) | $31.91 M(+33.5%) |
| Mar 2019 | - | $8.56 M(+7.7%) | $23.90 M(+55.8%) |
| Dec 2018 | $29.13 M(+34.3%) | $7.95 M(+7.5%) | $15.34 M(+107.5%) |
| Sep 2018 | - | $7.39 M | $7.39 M |
| Dec 2017 | $21.69 M | - | - |
FAQ
- What is Vir Biotechnology annual SGA?
- What is the all time high annual SGA for Vir Biotechnology?
- What is Vir Biotechnology annual SGA year-on-year change?
- What is Vir Biotechnology quarterly SGA?
- What is the all time high quarterly SGA for Vir Biotechnology?
- What is Vir Biotechnology quarterly SGA year-on-year change?
- What is Vir Biotechnology TTM SGA?
- What is the all time high TTM SGA for Vir Biotechnology?
- What is Vir Biotechnology TTM SGA year-on-year change?
What is Vir Biotechnology annual SGA?
The current annual SGA of VIR is $119.03 M
What is the all time high annual SGA for Vir Biotechnology?
Vir Biotechnology all-time high annual SGA is $174.44 M
What is Vir Biotechnology annual SGA year-on-year change?
Over the past year, VIR annual SGA has changed by -$55.41 M (-31.76%)
What is Vir Biotechnology quarterly SGA?
The current quarterly SGA of VIR is $26.70 M
What is the all time high quarterly SGA for Vir Biotechnology?
Vir Biotechnology all-time high quarterly SGA is $55.78 M
What is Vir Biotechnology quarterly SGA year-on-year change?
Over the past year, VIR quarterly SGA has changed by -$3.56 M (-11.78%)
What is Vir Biotechnology TTM SGA?
The current TTM SGA of VIR is -$2.16 B
What is the all time high TTM SGA for Vir Biotechnology?
Vir Biotechnology all-time high TTM SGA is $1.54 B
What is Vir Biotechnology TTM SGA year-on-year change?
Over the past year, VIR TTM SGA has changed by -$2.31 B (-1552.40%)